BRIEF-FDA approves Celgene's lung cancer drug

Oct 12 (Reuters) - Celgene Corp :

* FDA approves abraxane� for the first-line treatment of advanced non-small cell lung cancer

* Additional regulatory submissions have been filed in Japan, Australia and New Zealand with anticipated decisions in 2013

* Source text* Further company coverage

((Bangalore Newsroom; +1 646 223 8780))